BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3012503)

  • 1. [Immunohistochemical detection of nuclear estrogen receptors with monoclonal antibodies in different types of breast cancer].
    Stegner HE; Jonat W; Maass H
    Pathologe; 1986 May; 7(3):156-63. PubMed ID: 3012503
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stability of steroid receptors from breast tumors at different storage temperatures].
    Locher GW; Burger H; Davis BW; Zava DT
    Pathologe; 1984 Mar; 5(2):82-5. PubMed ID: 6326078
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estrogen receptor status of breast cancer patients].
    Winzer KJ; Saul G; Sinn B; Kranz D; Wolff H; Rose H
    Zentralbl Chir; 1986; 111(15):915-20. PubMed ID: 3020841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptors in breast cancer; relationship to age, menstrual status and histological type.
    Gómez P; Luna G; Beltrán ME; Hernández F
    Arch Invest Med (Mex); 1987; 18(1):31-6. PubMed ID: 2820332
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal receptors and breast cancer. Review of the literature and personal experience].
    Gallo A; Baldi F; Giannantoni C; Dell'Agli P; Caselli G
    Minerva Chir; 1988 Mar; 43(5):429-32. PubMed ID: 2840607
    [No Abstract]   [Full Text] [Related]  

  • 6. [Estrogen receptors and clinical prognostic factors in breast cancer].
    Hernández JL; Lera JM; Fakih A; Gómez Portilla A; Vicente F; Zornoza G
    Rev Esp Oncol; 1983; 30(2):179-88. PubMed ID: 6097962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of histopathologic and immunohistochemical data (using the D5 antibody) and biochemical analysis in the study of estrogen receptors in breast carcinoma].
    Bussolati G; Pietribiasi F; Gugliotta P; Conti G; Di Carlo F
    Pathologica; 1987; 79(1059-1060):45-50. PubMed ID: 3441410
    [No Abstract]   [Full Text] [Related]  

  • 8. [Estrogen receptor status in breast carcinoma. Results of comparative immunohistochemical and biochemical studies].
    Köhler G; Bässler R
    Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1954-60. PubMed ID: 3024947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlations between receptor state and various clinico-morphological parameters: evaluation of circa 2000 cases of breast tumors].
    Lampertico P; Stagni F
    Pathologica; 1985; 77(1049):281-97. PubMed ID: 3008068
    [No Abstract]   [Full Text] [Related]  

  • 10. [Follow-up of patients with receptor state determined by radiometric and histochemical methods].
    De Giuli P; Gubetta L
    Pathologica; 1985; 77(1049):311-4. PubMed ID: 3008070
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluorescence microscopy determination of estrogen receptor activity in breast cancer].
    Frank K; Heine M; Remmele W
    Pathologe; 1980 Nov; 2(1):51-5. PubMed ID: 6258170
    [No Abstract]   [Full Text] [Related]  

  • 12. Estrogen receptors, antibodies and hormone dependent cancer.
    DeSombre ER; Greene GL; King WJ; Jensen EV
    Prog Clin Biol Res; 1984; 142():1-21. PubMed ID: 6538684
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of estrogen dependency of human breast cancers. I. Cytochemical study of estrogen receptor in human breast cancer tissue.
    Nishiki M; Yamane M; Amano K; Yasuda K; Okumichi T; Ezaki H
    Hiroshima J Med Sci; 1984 Jun; 33(2):157-61. PubMed ID: 6090348
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of estrogen receptor protein and histopathologic characteristics in 175 cases of breast carcinoma.
    Ahluwali CK; Verma U; Sundaram KR; Verma K
    Indian J Pathol Microbiol; 1987 Jul; 30(3):299-305. PubMed ID: 2835317
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormone receptors and precancerous lesions of the breast].
    Mignot L; Espie M; de Roquancourt A; Gorins A
    Pathol Biol (Paris); 1983 Nov; 31(9):761-4. PubMed ID: 6318180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of male breast cancer with special reference to the hormonal environment during chemoendocrine therapy].
    Saito K; Hotta T; Kobayashi S; Miura I; Sakuma S; Shimozato T; Torii T; Iwase H; Satake A; Nishida T
    Gan No Rinsho; 1985 Oct; 31(13):1727-30. PubMed ID: 3001383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Statistical analysis of lectin and hormone receptor findings in 306 breast cancers].
    Hülter FW; Schumacher M; Kunze WP
    Verh Dtsch Ges Pathol; 1985; 69():359-61. PubMed ID: 3006386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the receptor composition of breast tumors with their histological structure; effect of preoperative therapy].
    Kuz'mina ZV; Murav'eva NI; Ermilova VD; Vishniakova VV; Letiagin VP
    Vestn Akad Med Nauk SSSR; 1985; (8):83-7. PubMed ID: 2998115
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of hormone receptors in cancer of the breast. Presentation of 5-year results in Luxembourg].
    Hoffmann JP
    Bull Soc Sci Med Grand Duche Luxemb; 1986; 123(2):57-9. PubMed ID: 3802371
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.
    McCarty KS; Szabo E; Flowers JL; Cox EB; Leight GS; Miller L; Konrath J; Soper JT; Budwit DA; Creasman WT
    Cancer Res; 1986 Aug; 46(8 Suppl):4244s-4248s. PubMed ID: 3524805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.